State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT05536739 N/A
Recruiting
Adaptive Hip Exoskeleton for Stroke Gait Enhancement
Condition
Stroke
Enrollment
12 pts
Location
United States
Sponsor
Georgia Institute of Technolog
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Condition
Myasthenia Gravis
Enrollment
199 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT06859801 N/A
Recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Tre...
Condition
Bone Cancer Metastatic
Enrollment
120 pts
Location
United States
Sponsor
Society of Interventional Onco
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06063122 N/A
Recruiting
Development of a Therapeutic Device to Improve Speech Sound Differentiation in P...
Condition
Premature Birth
Enrollment
203 pts
Location
United States
Sponsor
Thrive Neuromedical, LLC
NCT06229275 N/A
Recruiting
Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Col...
Condition
Cervical Cancer Screening
Enrollment
200 pts
Location
United States
Sponsor
Morehouse School of Medicine
NCT07006688 Phase 1
Recruiting
A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and...
Condition
IDH1-Mutated Malignancies
Enrollment
30 pts
Location
United States, Australia, Brazil
Sponsor
Servier Bio-Innovation LLC
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT07207369 Phase 3
Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Ad...
Condition
Acne Scars
Enrollment
395 pts
Location
United States
Sponsor
AbbVie
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT05937854 Phase 2
Recruiting
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
126 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07055451 Phase 1
Recruiting
Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to ...
Condition
HIV-1-infection
Enrollment
16 pts
Location
United States, South Africa
Sponsor
Gilead Sciences
NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Condition
Breast Neoplasms
Enrollment
421 pts
Location
United States, Canada, France
Sponsor
Eli Lilly and Company
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences